Keith Douglas Macmillan

Array ( [id] => 3741744 [patent_doc_number] => 05753712 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-19 [patent_title] => 'Treatment of migraine headaches and formulations' [patent_app_type] => 1 [patent_app_number] => 8/693158 [patent_app_country] => US [patent_app_date] => 1996-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 574 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/753/05753712.pdf [firstpage_image] =>[orig_patent_app_number] => 693158 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3874287 [patent_doc_number] => 05824662 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-20 [patent_title] => 'Treatment of global and focal ischemia using naaladase inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/718703 [patent_app_country] => US [patent_app_date] => 1996-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14294 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/824/05824662.pdf [firstpage_image] =>[orig_patent_app_number] => 718703 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3869704 [patent_doc_number] => 05837731 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-17 [patent_title] => 'Fatty acid treatment' [patent_app_type] => 1 [patent_app_number] => 8/721329 [patent_app_country] => US [patent_app_date] => 1996-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1966 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/837/05837731.pdf [firstpage_image] =>[orig_patent_app_number] => 721329 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3949794 [patent_doc_number] => 05955451 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-21 [patent_title] => 'Methods of enhancing the therapeutic activity of NSAIDS and compositions of zwitterionic phospholipids useful therein' [patent_app_type] => 1 [patent_app_number] => 8/719134 [patent_app_country] => US [patent_app_date] => 1996-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 29 [patent_no_of_words] => 15554 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/955/05955451.pdf [firstpage_image] =>[orig_patent_app_number] => 719134 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4023536 [patent_doc_number] => 05925678 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-20 [patent_title] => 'Use of N-acyl derivatives of aminoalcohols in the manufacture of a medicament for practicing neuroprotective action in neuropathological states connected with excitotoxicity' [patent_app_type] => 1 [patent_app_number] => 8/714113 [patent_app_country] => US [patent_app_date] => 1996-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5913 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/925/05925678.pdf [firstpage_image] =>[orig_patent_app_number] => 714113 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3862277 [patent_doc_number] => 05795902 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-18 [patent_title] => '3-substituted 2-oxindole-1 carboxamide pharmaceutical compositions' [patent_app_type] => 1 [patent_app_number] => 8/715748 [patent_app_country] => US [patent_app_date] => 1996-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2060 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/795/05795902.pdf [firstpage_image] =>[orig_patent_app_number] => 715748 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3883241 [patent_doc_number] => 05798388 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-25 [patent_title] => 'Method and composition for treating mammalian diseases caused by inflammatory response' [patent_app_type] => 1 [patent_app_number] => 8/709043 [patent_app_country] => US [patent_app_date] => 1996-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4394 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/798/05798388.pdf [firstpage_image] =>[orig_patent_app_number] => 709043 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4028386 [patent_doc_number] => 05902815 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-05-11 [patent_title] => 'Use of 5HT-2A serotonin agonists to prevent adverse effects of NMDA receptor hypofunction' [patent_app_type] => 1 [patent_app_number] => 8/709222 [patent_app_country] => US [patent_app_date] => 1996-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 17086 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/902/05902815.pdf [firstpage_image] =>[orig_patent_app_number] => 709222 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3961022 [patent_doc_number] => 05900428 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-05-04 [patent_title] => 'Pharmacological use of AII-receptor antagonists' [patent_app_type] => 1 [patent_app_number] => 8/696971 [patent_app_country] => US [patent_app_date] => 1996-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1168 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/900/05900428.pdf [firstpage_image] =>[orig_patent_app_number] => 696971 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4019094 [patent_doc_number] => 05906974 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-05-25 [patent_title] => 'Hemoglobin therapy in hemodialysis' [patent_app_type] => 1 [patent_app_number] => 8/701812 [patent_app_country] => US [patent_app_date] => 1996-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2039 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/906/05906974.pdf [firstpage_image] =>[orig_patent_app_number] => 701812 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3850706 [patent_doc_number] => 05767091 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-16 [patent_title] => 'Analgesic effect enhancing preparations' [patent_app_type] => 1 [patent_app_number] => 8/696819 [patent_app_country] => US [patent_app_date] => 1996-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 5961 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 175 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/767/05767091.pdf [firstpage_image] =>[orig_patent_app_number] => 696819 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3809671 [patent_doc_number] => 05811436 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-22 [patent_title] => 'Oral liquid compositions containing paroxetine resinate' [patent_app_type] => 1 [patent_app_number] => 8/682799 [patent_app_country] => US [patent_app_date] => 1996-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1075 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/811/05811436.pdf [firstpage_image] =>[orig_patent_app_number] => 682799 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3794119 [patent_doc_number] => 05780514 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-14 [patent_title] => 'Antiprotozoal medicaments' [patent_app_type] => 1 [patent_app_number] => 8/680835 [patent_app_country] => US [patent_app_date] => 1996-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6003 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/780/05780514.pdf [firstpage_image] =>[orig_patent_app_number] => 680835 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3741592 [patent_doc_number] => 05753702 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-19 [patent_title] => 'Arachidonic acid metabolite, 16-hete' [patent_app_type] => 1 [patent_app_number] => 8/652327 [patent_app_country] => US [patent_app_date] => 1996-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9866 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/753/05753702.pdf [firstpage_image] =>[orig_patent_app_number] => 652327 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3838355 [patent_doc_number] => 05846975 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-08 [patent_title] => 'Use of amino hydrogenated quinazoline compounds and derivatives thereof for abstaining from drug dependence' [patent_app_type] => 1 [patent_app_number] => 8/640781 [patent_app_country] => US [patent_app_date] => 1996-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6286 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 309 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/846/05846975.pdf [firstpage_image] =>[orig_patent_app_number] => 640781 [rel_patent_id] =>[rel_patent_doc_number] =>)